+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Prostate Health Market - Global Forecast 2026-2032- Product Image
Prostate Health Market - Global Forecast 2026-2032- Product Image
New

Prostate Health Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5639425
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The prostate health market is undergoing significant transformation, driven by demographic shifts, technological advancements, and evolving clinical expectations. Senior decision-makers require clear insight into the forces fundamentally reshaping this sector to align strategies for sustainable advantage.

Market Snapshot

The Prostate Health Market grew from USD 63.88 billion in 2025 to USD 71.01 billion in 2026. It is projected to expand at a CAGR of 13.35%, reaching USD 153.63 billion by 2032.

Demand is escalating due to rising patient expectations for personalized and less invasive diagnostics, ongoing clinical advances in biomarkers and imaging, and evolving regulatory frameworks that emphasize evidence and interoperability.

Scope & Segmentation

This report examines major clinical, commercial, and regulatory drivers shaping prostate health globally. The market is segmented to enable stakeholders to target optimal opportunities and streamline operational strategy:

  • Product Types: Diagnostic kits (including PSA tests—conventional and high-sensitivity, biopsy devices, imaging agents), drugs (chemotherapy, hormone therapy, immunotherapy, radiopharmaceuticals, further subdivided into androgen receptor antagonists and LHRH agonists), imaging systems (CT, MRI, PET, ultrasound—transabdominal and transrectal formats).
  • Indications: Benign prostatic hyperplasia, prostate cancer, prostatitis correspond to distinct diagnostic and therapy pathways.
  • End Users: Ambulatory care centers, diagnostic laboratories, hospitals, and specialty clinics, each with specific capital and workflow needs.
  • Distribution Channels: Direct tender, hospital pharmacies, online and retail pharmacies respond to differing procurement models and patient access priorities.
  • Technology Types: Digital pathology, image analysis software, molecular diagnostics (biomarker tests such as PCA3, TMPRSS2-ERG; next-generation sequencing panels; PCR assays including real-time and digital PCR), with AI tools enabling greater automation and analytic precision.
  • Geographies: Americas, Europe Middle East Africa, and Asia-Pacific are analyzed for their regulatory environments, reimbursement models, and adoption pathways.

Key Takeaways

  • Minimally invasive diagnostic and therapeutic technologies are enabling earlier intervention and improved patient stratification, supporting a shift toward personalized care models.
  • Strategic partnerships across diagnostics, imaging, and therapeutics are central to offering bundled solutions that meet multidisciplinary needs across healthcare settings.
  • Regulatory evolution is emphasizing comprehensive evidence, especially post-market surveillance and platform interoperability, driving higher standards for market entry and expansion.
  • Operational alignment—including training, ongoing support, and flexible service-based commercial models—accelerates adoption, particularly for capital-intensive imaging systems.
  • Regional nuances in infrastructure, payer behavior, and regulatory review require stakeholders to tailor market access and commercialization strategies to local realities.

Tariff Impact

Expected tariff changes in 2025 may disrupt procurement and supply chains in prostate health. Cost pressures on imaging equipment, diagnostic kits, and radiopharmaceuticals could prompt providers to reconsider capital allocations and sourcing strategies. Pharmaceutical and device suppliers may respond by diversifying regional manufacturing or exploring tariff-exempt partnerships. Healthcare systems could shift toward lower-cost or locally-produced alternatives, while service-oriented and flexible purchasing models—such as equipment-as-a-service or extended financing—may become more prevalent. Decision-makers should model scenarios and adapt supplier networks to mitigate disruption and maintain patient access.

Methodology & Data Sources

This analysis integrates structured interviews with clinical and industry stakeholders, secondary review of peer-reviewed literature, regulatory records, and comprehensive aggregation of public clinical and commercial data. Quantitative and qualitative triangulation ensures that strategic findings are transparent, replicable, and rooted in regulatory-compliant evidence and consensus clinical trends.

Why This Report Matters

  • Provides actionable intelligence on technology adoption, clinical value, and evolving regulatory landscapes for prostate health solutions.
  • Supports strategic planning with granular segmentation, outcome-focused insights, and tailored recommendations for supply chain resilience and commercial differentiation.
  • Helps decision-makers prioritize investments by highlighting the operational and market realities shaping adoption, from clinical workflow integration to end-user segmentation.

Conclusion

Aligning diagnostic precision, therapeutic innovation, and robust evidence generation is essential for future success in the prostate health market. Organizations that integrate these strategies with regionally-informed commercialization will be well-positioned for sustained impact and competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Prostate Health Market, by Product Type
8.1. Diagnostic Kits
8.1.1. Biopsy Devices
8.1.2. Imaging Agents
8.1.3. Psa Tests
8.1.3.1. Conventional
8.1.3.2. High Sensitivity
8.2. Drugs
8.2.1. Chemotherapy
8.2.2. Hormone Therapy
8.2.3. Immunotherapy
8.2.4. Radiopharmaceuticals
8.3. Imaging Systems
8.3.1. Computed Tomography
8.3.2. Magnetic Resonance Imaging
8.3.3. Positron Emission Tomography
8.3.4. Ultrasound
8.3.4.1. Transabdominal
8.3.4.2. Transrectal
9. Prostate Health Market, by Indication
9.1. Benign Prostatic Hyperplasia
9.2. Prostate Cancer
9.3. Prostatitis
10. Prostate Health Market, by Technology Type
10.1. Digital Pathology
10.1.1. Ai Based Analysis
10.1.2. Whole Slide Imaging
10.2. Image Analysis Software
10.3. Molecular Diagnostics
10.3.1. Biomarker Tests
10.3.1.1. Pca3
10.3.1.2. Tmprss2 Erg
10.3.2. Next Generation Sequencing Panels
10.3.3. Polymerase Chain Reaction Assays
11. Prostate Health Market, by End User
11.1. Ambulatory Care Centers
11.2. Diagnostic Laboratories
11.3. Hospitals
11.4. Specialty Clinics
12. Prostate Health Market, by Distribution Channel
12.1. Direct Tender
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Prostate Health Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Prostate Health Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Prostate Health Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Prostate Health Market
17. China Prostate Health Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. Active Biotech AB
18.7. Bayer AG
18.8. Dendreon Pharmaceuticals, LLC
18.9. Endo International plc
18.10. Ipsen S.A.
18.11. Johnson & Johnson
18.12. MacroGenics, Inc.
18.13. Merck & Co., Inc.
18.14. Myonova Therapeutics, Inc.
18.15. Myovant Sciences Ltd.
18.16. Myriad Genetics, Inc.
18.17. Nippon Shinyaku Co., Ltd.
18.18. Novartis AG
List of Figures
FIGURE 1. GLOBAL PROSTATE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PROSTATE HEALTH MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PROSTATE HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PROSTATE HEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PROSTATE HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PROSTATE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PROSTATE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PROSTATE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOPSY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOPSY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOPSY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HIGH SENSITIVITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HIGH SENSITIVITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HIGH SENSITIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSABDOMINAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSABDOMINAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSABDOMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSRECTAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSRECTAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSRECTAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AI BASED ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AI BASED ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AI BASED ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PROSTATE HEALTH MARKET SIZE, BY WHOLE SLIDE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PROSTATE HEALTH MARKET SIZE, BY WHOLE SLIDE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PROSTATE HEALTH MARKET SIZE, BY WHOLE SLIDE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PCA3, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PCA3, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PCA3, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TMPRSS2 ERG, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TMPRSS2 ERG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TMPRSS2 ERG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PROSTATE HEALTH MARKET SIZE, BY NEXT GENERATION SEQUENCING PANELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PROSTATE HEALTH MARKET SIZE, BY NEXT GENERATION SEQUENCING PANELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PROSTATE HEALTH MARKET SIZE, BY NEXT GENERATION SEQUENCING PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL PROSTATE HEALTH MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL PROSTATE HEALTH MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL PROSTATE HEALTH MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS PROSTATE HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. EUROPE PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. EUROPE PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 193. EUROPE PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 194. EUROPE PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 195. EUROPE PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 196. EUROPE PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 197. EUROPE PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 198. EUROPE PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 199. EUROPE PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 200. EUROPE PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 201. EUROPE PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. EUROPE PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. AFRICA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. AFRICA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 220. AFRICA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 221. AFRICA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 222. AFRICA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 223. AFRICA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 224. AFRICA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 225. AFRICA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 226. AFRICA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 227. AFRICA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 228. AFRICA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 229. AFRICA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. AFRICA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL PROSTATE HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 246. ASEAN PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. ASEAN PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. ASEAN PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 249. ASEAN PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 250. ASEAN PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 251. ASEAN PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 252. ASEAN PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 253. ASEAN PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 254. ASEAN PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 255. ASEAN PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 256. ASEAN PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 257. ASEAN PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 258. ASEAN PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. ASEAN PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 260. GCC PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. GCC PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 262. GCC PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 263. GCC PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 264. GCC PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 265. GCC PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 266. GCC PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 267. GCC PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 268. GCC PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 269. GCC PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 270. GCC PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 271. GCC PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 272. GCC PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. GCC PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 288. BRICS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. BRICS PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 290. BRICS PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 291. BRICS PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 292. BRICS PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 293. BRICS PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 294. BRICS PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 295. BRICS PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 296. BRICS PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 297. BRICS PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 298. BRICS PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 299. BRICS PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 300. BRICS PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 301. BRICS PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 302. G7 PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 303. G7 PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 304. G7 PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 305. G7 PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 306. G7 PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 307. G7 PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 308. G7 PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 309. G7 PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 310. G7 PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 311. G7 PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 312. G7 PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 313. G7 PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 314. G7 PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 315. G7 PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 316. NATO PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 317. NATO PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 318. NATO PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 319. NATO PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 320. NATO PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 321. NATO PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 322. NATO PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 323. NATO PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 324. NATO PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 325. NATO PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 326. NATO PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 327. NATO PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 328. NATO PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 329. NATO PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 330. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 331. UNITED STATES PROSTATE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 332. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 333. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2032 (USD MILLION)
TABLE 334. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2032 (USD MILLION)
TABLE 335. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 336. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 337. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 338. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 339. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 340. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 341. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 342. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2032 (USD MILLION)
TABLE 343. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2032

Companies Mentioned

The key companies profiled in this Prostate Health market report include:
  • AbbVie Inc.
  • Active Biotech AB
  • Bayer AG
  • Dendreon Pharmaceuticals, LLC
  • Endo International plc
  • Ipsen S.A.
  • Johnson & Johnson
  • MacroGenics, Inc.
  • Merck & Co., Inc.
  • Myonova Therapeutics, Inc.
  • Myovant Sciences Ltd.
  • Myriad Genetics, Inc.
  • Nippon Shinyaku Co., Ltd.
  • Novartis AG

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 71.01 Billion
Forecasted Market Value ( USD ) by 2032 $ 153.63 Billion
Compound Annual Growth Rate13.3%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Prostate Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Image

Prostate Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Prostate Cancer Nuclear Medicine Diagnostics Market - Global Forecast 2026-2032 - Product Image

Prostate Cancer Nuclear Medicine Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Prostate Cancer Biomarkers Market Size, Share & Trends Analysis Report by Type (Genetic Biomarkers, Cell-based Biomarkers, Metabolomic Biomarkers), Application, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Prostate Cancer Biomarkers Market Size, Share & Trends Analysis Report by Type (Genetic Biomarkers, Cell-based Biomarkers, Metabolomic Biomarkers), Application, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
U.S. Prostate Cancer Biomarkers Market Size, Share & Trends Analysis Report By Type (Protein Biomarkers, Metabolomic Biomarkers), By Application (Screening & Early Detection, Companion Diagnostics), By End-use, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Prostate Cancer Biomarkers Market Size, Share & Trends Analysis Report By Type (Protein Biomarkers, Metabolomic Biomarkers), By Application (Screening & Early Detection, Companion Diagnostics), By End-use, And Segment Forecasts, 2025 - 2033

  • Report
  • 120 Pages
  • United States
From
Prostate Specific Antigen (Psa) Test Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Prostate Specific Antigen (Psa) Test Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Prostate Health Market

The Prostate Health market is a subset of the pharmaceutical industry focused on the development and sale of drugs to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it are typically hormone therapy, chemotherapy, and radiation therapy. These drugs are used to reduce the size of the tumor, slow its growth, and reduce the risk of metastasis. In addition, some drugs are used to reduce the side effects of prostate cancer treatments, such as fatigue, nausea, and sexual dysfunction. The Prostate Health market is highly competitive, with many companies offering a variety of drugs to treat prostate cancer. Some of the major players in the market include AstraZeneca, Pfizer, Merck, and Johnson & Johnson. Other companies in the market include AbbVie, Bristol-Myers Squibb, and Sanofi. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.